BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Vanessa Costilla, Neha Mathur, Julio A. Gutierrez. Mechanisms of Virologic Failure with Direct-Acting Antivirals in Hepatitis C and Strategies for RetreatmentClinics in Liver Disease 2015; 19(4): 641 doi: 10.1016/j.cld.2015.06.005
2
Satoshi Hiramine, Norihiro Furusyo, Eiichi Ogawa, Makoto Nakamuta, Eiji Kajiwara, Hideyuki Nomura, Kazufumi Dohmen, Kazuhiro Takahashi, Takeaki Satoh, Koichi Azuma, Akira Kawano, Toshimasa Koyanagi, Kazuhiro Kotoh, Shinji Shimoda, Jun Hayashi. Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis CWorld Journal of Hepatology 2015; 7(26): 2688-2695 doi: 10.4254/wjh.v7.i26.2688
3
Cristina Romero-López, Alfredo Berzal-Herranz. Structure-function relationship in viral RNA genomes: The case of hepatitis C virusWorld Journal of Medical Genetics 2014; 4(2): 6-18 doi: 10.5496/wjmg.v4.i2.6
4
Patrick Arbuthnot. Gene Therapy for Viral Infections2015; : 1 doi: 10.1016/B978-0-12-410518-8.00001-6
5
Jean-Jacques Tudesq, Catherine Dunyach-Remy, Christophe Combescure, Régine Doncesco, Didier Laureillard, Jean-Philippe Lavigne, Albert Sotto, Cristian Apetrei. Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patientsPLOS ONE 2017; 12(9): e0183372 doi: 10.1371/journal.pone.0183372
6
Ludovico Abenavoli, Mario Masarone, Valentina Peta, Natasa Milic, Nazarii Kobyliak, Samir Rouabhia, Marcello Persico. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3World Journal of Gastroenterology 2014; 20(41): 15233-15240 doi: 10.3748/wjg.v20.i41.15233
7
Sara Corchado, Luis F. López-Cortés, Antonio Rivero-Juárez, Almudena Torres-Cornejo, Antonio Rivero, Mercedes Márquez-Coello, José-Antonio Girón-González, Wenyu Lin. Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected PatientsPLoS ONE 2014; 9(7): e101760 doi: 10.1371/journal.pone.0101760
8
XIAO-HUA JIANG, YU-TAO XIE, BO JIANG, MENG-YING TANG, TAO MA, HUA PENG. Inhibition of expression of hepatitis C virus 1b genotype core and NS4B genes in HepG2 cells using artificial microRNAsMolecular Medicine Reports 2015; 12(2): 1905 doi: 10.3892/mmr.2015.3571
9
Robert Flisiak, Mitchell Shiffman, Juan Arenas, Hugo Cheinquer, Igor Nikitin, Yuping Dong, Khurram Rana, Subasree Srinivasan, Chien-Wei Su. A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis CPLOS ONE 2016; 11(10): e0164563 doi: 10.1371/journal.pone.0164563
10
Patrick Arbuthnot. Gene Therapy for Viral Infections2015; : 191 doi: 10.1016/B978-0-12-410518-8.00007-7
11
THT Nguyen, J Guedj. HCV Kinetic Models and Their Implications in Drug DevelopmentCPT: Pharmacometrics & Systems Pharmacology 2015; 4(4): 231 doi: 10.1002/psp4.28
12
Mohsen Koolivand, Zeinab Allamehzadeh, Ali Ahmadi, Ramezan Ali Taheri, Kazem Hassanpour, Afshin Zeini, Gholamreza Farnoosh. The Study of IFNL3 Gene Rs12979860 Polymorphism in the Hepatitis C Virus Patients and Healthy Population in Tehran Province, IranJundishapur Journal of Microbiology 2020; 13(5) doi: 10.5812/jjm.95798
13
Min Gu Kang, Min Jung Kang, Eunhee Ji, Bong Kyu Yoo. Meta-analysis of the Efficacy and Safety of Grazoprevir and Elbasvir for the Treatment of Hepatitis C Virus InfectionKorean Journal of Clinical Pharmacy 2017; 27(3): 150 doi: 10.24304/kjcp.2017.27.3.150
14
Yuan-Hung Kuo, Pao-Fei Chen, Jing-Houng Wang, Kuo-Chin Chang, Kwong-Ming Kee, Ming-Chao Tsai, Chun-Yin Lin, Sheng-Che Lin, Lin-San Tsai, Shu-Chuan Chen, Sheng-Nan Lu, Chen-Hua Liu. Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical CarePLOS ONE 2015; 10(5): e0126031 doi: 10.1371/journal.pone.0126031
15
Partha K. Chandra, Feyza Gunduz, Sidhartha Hazari, Ramazan Kurt, Rajesh Panigrahi, Bret Poat, David Bruce, Ari J. Cohen, Humberto E. Behorquez, Ian Carmody, George Loss, Luis A. Balart, Tong Wu, Srikanta Dash, Ranjit Ray. Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver CirrhosisPLoS ONE 2014; 9(9): e108616 doi: 10.1371/journal.pone.0108616
16
Victoria Belousova, Ahmed A. Abd-Rabou, Shaker A. Mousa. Recent advances and future directions in the management of hepatitis C infectionsPharmacology & Therapeutics 2015; 145: 92 doi: 10.1016/j.pharmthera.2014.09.002
17
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatmentWorld Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
18
Jun Itakura, Masayuki Kurosaki, Hitomi Takada, Natsuko Nakakuki, Syuya Matsuda, Kouichi Gondou, Yu Asano, Nobuhiro Hattori, Yoshie Itakura, Nobuharu Tamaki, Yutaka Yasui, Shoko Suzuki, Takanori Hosokawa, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Takahashi, Syinya Maekawa, Nobuyuki Enomoto, Namiki Izumi. Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapyHepatology Research 2015; 45(10): E115 doi: 10.1111/hepr.12474
19
Poor response to direct-acting antiviral therapy in HCV-infected elderly population: a real-life cohort study based on GeneXpert® technologyFuture Virology 2018; 13(7): 467 doi: 10.2217/fvl-2017-0158
20
Holly Hagan, Joshua Neurer, Ashly E Jordan, Don C Des Jarlais, Jennifer Wu, Kirk Dombrowski, Bilal Khan, Ronald Scott Braithwaite, Jason Kessler. Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysisSystematic Reviews 2014; 3(1) doi: 10.1186/2046-4053-3-31
21
Zehui Yan, Yuming Wang. Viral and host factors associated with outcomes of hepatitis C virus infectionMolecular Medicine Reports 2017; 15(5): 2909 doi: 10.3892/mmr.2017.6351
22
Lei Chen, Jing Lu, Tao Huang, Jun Yin, Lai Wei, Yu-Dong Cai, Lisa F. P. Ng. Finding Candidate Drugs for Hepatitis C Based on Chemical-Chemical and Chemical-Protein InteractionsPLoS ONE 2014; 9(9): e107767 doi: 10.1371/journal.pone.0107767
23
Braira Wahid, Shazia Rafique, Komal Saleem, Amjad Ali, Muhammad Idrees. An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral LoadJournal of Interferon & Cytokine Research 2018; 38(3): 122 doi: 10.1089/jir.2017.0129
24
Naveen Tmu, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora. Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated CirrhosisJournal of Clinical and Experimental Hepatology 2019; 9(1): 4 doi: 10.1016/j.jceh.2018.02.009
25
Nobuhisa Akamatsu, Yasuhiko Sugawara, Norihiro Kokudo. Asunaprevir (BMS-650032) for the treatment of hepatitis C virusExpert Review of Anti-infective Therapy 2015; 13(11): 1307 doi: 10.1586/14787210.2015.1091724
26
Lourianne Nascimento Cavalcante, André Castro Lyra. Predictive factors associated with hepatitis C antiviral therapy responseWorld Journal of Hepatology 2015; 7(12): 1617-1631 doi: 10.4254/wjh.v7.i12.1617
27
Raíssa Neves Fagundes, Lincoln Eduardo Villela Vieira de Castro Ferreira, Fábio Heleno de Lima Pace. Health-Related Quality of Life in patients with hepatitis C in double and triple therapyRevista da Escola de Enfermagem da USP 2015; 49(6): 937 doi: 10.1590/S0080-623420150000600009
28
Kattareeya Kumthip, Niwat Maneekarn. The role of HCV proteins on treatment outcomesVirology Journal 2015; 12(1) doi: 10.1186/s12985-015-0450-x
29
Eleanor M. Wilson, Elana S. Rosenthal, Sarah Kattakuzhy, Lydia Tang, Shyam Kottilil. Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis CClinical Microbiology Reviews 2017; 30(1): 23 doi: 10.1128/CMR.00037-16